GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (BUE:AZN) » Definitions » Shiller PE Ratio

AstraZeneca (BUE:AZN) Shiller PE Ratio : 57.66 (As of May. 12, 2024)


View and export this data going back to . Start your Free Trial

What is AstraZeneca Shiller PE Ratio?

As of today (2024-05-12), AstraZeneca's current share price is ARS214.50. AstraZeneca's E10 for the quarter that ended in Mar. 2024 was ARS3.72. AstraZeneca's Shiller PE Ratio for today is 57.66.

The historical rank and industry rank for AstraZeneca's Shiller PE Ratio or its related term are showing as below:

BUE:AZN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 4.62   Med: 23.7   Max: 75.22
Current: 66.95

During the past years, AstraZeneca's highest Shiller PE Ratio was 75.22. The lowest was 4.62. And the median was 23.70.

BUE:AZN's Shiller PE Ratio is ranked worse than
85.85% of 530 companies
in the Drug Manufacturers industry
Industry Median: 25.165 vs BUE:AZN: 66.95

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AstraZeneca's adjusted earnings per share data for the three months ended in Mar. 2024 was ARS1,179.500. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ARS3.72 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AstraZeneca Shiller PE Ratio Historical Data

The historical data trend for AstraZeneca's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Shiller PE Ratio Chart

AstraZeneca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.82 35.15 52.72 71.22 59.93

AstraZeneca Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.34 66.74 65.79 59.93 57.80

Competitive Comparison of AstraZeneca's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, AstraZeneca's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Shiller PE Ratio falls into.



AstraZeneca Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AstraZeneca's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=214.50/3.72
=57.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, AstraZeneca's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1179.5/130.0000*130.0000
=1,179.500

Current CPI (Mar. 2024) = 130.0000.

AstraZeneca Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 5.119 99.800 6.668
201409 1.684 100.000 2.189
201412 -2.138 99.900 -2.782
201503 3.881 99.600 5.066
201506 4.998 100.100 6.491
201509 5.641 100.200 7.319
201512 8.154 100.400 10.558
201603 7.448 100.400 9.644
201606 -0.033 101.000 -0.042
201609 11.933 101.500 15.284
201612 22.986 102.200 29.239
201703 6.475 102.700 8.196
201706 6.265 103.500 7.869
201709 9.463 104.300 11.795
201712 19.668 105.000 24.351
201803 5.440 105.100 6.729
201806 6.734 105.900 8.266
201809 12.512 106.600 15.259
201812 30.918 107.100 37.529
201903 18.372 107.000 22.321
201906 4.021 107.900 4.845
201909 12.863 108.400 15.426
201912 14.346 108.500 17.189
202003 36.621 108.600 43.837
202006 39.707 108.800 47.444
202009 36.378 109.200 43.307
202012 63.476 109.400 75.429
202103 106.294 109.700 125.964
202106 39.787 111.400 46.430
202109 -107.558 112.400 -124.400
202112 -22.218 114.700 -25.182
202203 26.843 116.500 29.954
202206 27.676 120.500 29.858
202209 145.897 122.300 155.083
202212 97.237 125.300 100.884
202303 229.158 126.800 234.941
202306 280.800 129.400 282.102
202309 307.956 130.100 307.719
202312 223.820 130.000 223.820
202403 1,179.500 130.000 1,179.500

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AstraZeneca  (BUE:AZN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AstraZeneca Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca (BUE:AZN) Business Description

Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.

AstraZeneca (BUE:AZN) Headlines

From GuruFocus